Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.
Business Model:
Revenue: $13.2M
Employees: 51-200
Address: 1300 York Avenue
City: New York
State: NY
Zip: 10065
Country: US
Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro. The expansion capacity is on an unprecedented scale when compared to any other competing technology, and it is achieved without the requirement for costly media additives. This process can meet the needs of a broad range of therapeutic, diagnostic, and research applications. We look forward to the expansive application of this technology to help fulfill the promise of tissue-specific engineering and organ-regeneration.
Contact Phone:
+15307459560
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2021 | Private Equity Round | $58.1M | 12/2022 | Grant | 1 | $15M |
California Institute for Regenerative Medicine California Institute for Regenerative Medicine |
3/2013 | Venture Round | $4M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|